Biocartis’ EGFR Mutation Test gains IVDR Class C CDx certification
Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System certificate, making it the first Idylla Test to achieve Class C companion diagnostic (CDx) in vitro medical device status. The post Biocartis’ EGFR Mutation Test gains IVDR Class C CDx certification appeared first on Medical Device Network.

The post Biocartis’ EGFR Mutation Test gains IVDR Class C CDx certification appeared first on Medical Device Network.